北美皮肤癌诊断市场预测至 2028 年 - COVID-19 影响和按类型（黑色素瘤和非黑色素瘤）和筛查类型（血液测试、皮肤镜检查、影像测试、淋巴结活检和皮肤活检）进行的区域分析
No. of Pages: 107 | Report Code: TIPRE00029075 | Category: Life Sciences
No. of Pages: 107 | Report Code: TIPRE00029075 | Category: Life Sciences
乳腺癌、肺、结肠和直肠、前列腺癌、皮肤癌和胃癌在该地区非常常见。根据世界卫生组织的数据，2020年报告的新病例中约有120万是皮肤癌病例。皮肤癌是迄今为止所有癌症类型中最常见的。黑色素瘤和非黑色素瘤是皮肤癌的两种类型。尽管黑色素瘤约占皮肤癌病例总数的 1%，但它导致的皮肤癌死亡人数最多。黑色素瘤的发病率在过去几十年里迅速增加，而且也随着年龄的增长而变化。据美国癌症协会预测，到 2022 年，美国每年新诊断的癌症病例数可能会达到约 99,780 例；其中，57,180 名患者可能是男性，42,600 名患者可能是女性。报告进一步指出，预计将有 7,650 人死于黑色素瘤（其中 5,080 名男性和 2,570 名女性）。根据皮肤癌基金会的数据，2012 年至 2022 年期间，每年诊断出的侵袭性黑色素瘤病例增加了 31%。因此，未来几年皮肤癌的发病率可能会增加，从而导致对皮肤癌诊断的需求更高。
随着新的功能和技术，供应商吸引新客户并扩大其在新兴市场的足迹。这一因素正在推动皮肤癌诊断市场以令人鼓舞的复合年增长率增长。
皮肤癌诊断市场细分为类型和筛选类型。根据类型，市场分为黑色素瘤和非黑色素瘤。根据筛查类型，市场分为皮肤活检、皮肤镜检查、淋巴结活检、影像学检查和血液检查。根据国家/地区，市场分为美国、加拿大和墨西哥。
SkylineDx BV； AMLo 生物科学有限公司； DermLite 有限责任公司；生物梅里埃公司；维里斯金公司；城堡生物科学公司；皮肤科技公司； F.霍夫曼-拉罗氏有限公司；和 Michelson Diagnostics Ltd. 是北美皮肤癌诊断市场的领先公司之一。
Strategic insights for North America Skin Cancer Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 1,423.0 Million |
| Market Size by 2028 | US$ 2,354.2 Million |
| Global CAGR (2021 - 2028) | 7.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Skin Cancer Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Skin Cancer Diagnostics Market is valued at US$ 1,423.0 Million in 2021, it is projected to reach US$ 2,354.2 Million by 2028.
As per our report North America Skin Cancer Diagnostics Market, the market size is valued at US$ 1,423.0 Million in 2021, projecting it to reach US$ 2,354.2 Million by 2028. This translates to a CAGR of approximately 7.5% during the forecast period.
The North America Skin Cancer Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Skin Cancer Diagnostics Market report:
The North America Skin Cancer Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Skin Cancer Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Skin Cancer Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Skin Cancer Diagnostics Market
